The United States Food and Drug Administration (US FDA) has launched an investigation into the products of major Indian spice manufacturers MDH and Everest following concerns raised by Hong Kong over alleged high levels of cancer-causing pesticides in their products.
US FDA Review Amid Contamination Concerns
A spokesperson from the US FDA told Reuters on Friday that the agency is actively gathering information regarding the situation on the subject. This development marks the first official acknowledgement of the US FDA’s investigation of Indian spice products for potential contamination.
Also Read | US FTC Votes to Ban Majority of Noncompete Agreements, Citing Worker Freedom Concerns
International Halts and Recalls
Moreover, Hong Kong recently suspended the sale of 3 MDH spice blends and one Everest spice blend, citing concerns over high levels of ethylene oxide, a substance considered unfit for human consumption and associated with prolonged exposure. Singapore also ordered the recall of the Everest spice blend for similar reasons, underscoring the international dimension of the issue.
Silent Response from Manufacturers
So far, neither MDH nor Everest, 2 of India’s largest spice traders, have responded to the allegations and reached out to Reuters multiple times for comment, but neither company responded. MDH and Everest’s spices have a substantial presence not only in the Indian market but also in European, Asian and North American markets. The potential consequences of the allegations of contamination go beyond the borders of India and concern consumers and regulators around the world.
Indian Regulatory Response
Moreover, Responding to International actions, India’s food regulator, the Food Safety and Standards Authority of India (FSSAI), has also initiated quality checks on MDH and Everest’s products. Additionally, the Spices Board of India, responsible for regulating spice exports, is cooperating with the relevant authorities to further investigate the matter.
Also Read | Nestle India Surpasses Expectations with Robust Q4 Performance
Previous Incidents and Ongoing Inspections
This is not the first case of controversy regarding MDH products. In 2019, some batches were recalled in the US due to Salmonella contamination. As inspections begin at MDH and Everest’s manufacturing plants, stakeholders are eager to determine the root cause of the reported quality issues.
